Real-World Effectiveness of Up to 12-Month Tralokinumab Treatment in Adults With Atopic Dermatitis Who Previously Discontinued Dupilumab or Janus Kinase Inhibitors. (2026). SKIN The Journal of Cutaneous Medicine, 10(2), s728. https://doi.org/10.25251/wx06pe13